David Shaw’s PhenomeX Inc. Common Stock CELL Stock Holding History

David Shaw’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40,000	Closed	-$727K	–	6112
2021 Q4	$727K	Buy	+40,000	New	+$863K	﹤0.01%	4161

David Shaw's CELL Position: Q4 2023 in Review

David Shaw sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 148,923 shares — an estimated $149K sold.

David Shaw first reported a position in CELL in Q4 2020 and held it in 8 quarters. The position peaked at $2.91M in Q4 2022. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

David Shaw reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
David Shaw sold 148,923 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $149K.
David Shaw first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 8 quarters.
David Shaw's PhenomeX Inc. Common Stock position peaked at $2.91M in Q4 2022.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.